The role of oxidative stress in the development of pulmonary arteriovenous malformations after cavopulmonary anastomosis

Journal of Thoracic and Cardiovascular Surgery

Volumn 124, Issue 3, 2002, Pages 479-485

  Malhotra, Sunil P ^a   Reddy, V Mohan ^a   Thelitz, Stephan ^a   He, You Ping ^a   McMullan, D Michael ^a   Hanley, Frank L ^a   Riemer, R Kirk ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; HEAT SHOCK PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS MALFORMATION; ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DISEASE PREDISPOSITION; EFFLUENT; ENDOTHELIUM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GLUT1 GENE; HO1 GENE; INFERIOR CAVA VEIN; LAMB; LUNG ARTERY BANDING; LUNG BLOOD FLOW; LUNG PARENCHYMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PULMONARY ARTERY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; WESTERN BLOTTING;

EID: 0036738056     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.120346     Document Type: Article

References (12)

1. Glenn WWL, Patino JF. Circulatory bypass of the right heart. I. Preliminary observations on the direct delivery of the vena caval blood into the pulmonary arterial circulation: azygos vein-pulmonary artery shunt. Yale J Biol Med. 1954;27:147-51.
2. Cloutier A, Ash JM, Smallhorn JF, Williams WG, Trusler GA, Rowe RD, et al. Abnormal distribution of pulmonary blood flow after the Glenn shunt or Fontan procedure: risk of development of arteriovenous fistulae. Circulation. 1985;72:471-9.
3. Chang RR, Alejos JC, Atkinson D, Jensen R, Drant S, Galindo A, et al. Bubble contrast echocardiography in detecting pulmonary arteriovenous shunting in children with univentricular heart after cavopulmonary anastomosis. J Am Coll Cardiol. 1999;33:2052-8.
4. Duncan BW, Kneebone JM, Chi EY, Hraksa V, Isik FF, Rosenthal GL, et al. A detailed histological analysis of pulmonary arteriovenous malformations in children with cyanotic congenital heart disease. J Thorac Cardiovasc Surg. 1999;117:931-8.
5. Abrams LD. Side-to-side cavopulmonary anastomosis for the palliation of the "primitive ventricle" [abstract]. Br Heart J. 1077;39:926.
6. Malhotra SP, Riemer RK, Thelitz S, He Y, Hanley FL, Reddy VM. Superior cavopulmonary anastomosis suppresses pulmonary angiotensin-converting enzyme activity and expression. J Thorac Cardiovasc Surg. 2001;122:464-9.
7. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev. 2000;14:1983-91.
8. Semenza GL. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol. 2000;59:47-53.
9. Bernstein HS, Brook MM, Silverman NH, Bristow J. Development of pulmonary arteriovenous fistulae in children after cavopulmonary shunt. Circulation. 1995;92:309-14.
10. Riemer RK, Buscher C, Bansal RK, Black SM, He Y, Natuzzi E. Increased expression of nitric oxide synthase in the myometrium of the pregnant rat uterus. Am J Physiol. 1997;272:E1008-15.
11. Srivastava D, Preminger T, Lock JE, Mandell V, Keane JF, Mayer JE, et al. Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation. 1995;92:1217-22.
12. Shah MJ, Rychik J, Fogel MA, Murphy JD, Jacobs ML. Pulmonary AV malformations after cavopulmonary connection: resolution after inclusion of hepatic veins in the pulmonary circulation. Ann Thorac Surg. 1997;63:960-3.